Literature DB >> 26046724

Use of an online epilepsy diary to characterize repetitive seizures.

Robert S Fisher1, Eyal Bartfeld2, Joyce A Cramer3.   

Abstract

SIGNIFICANCE: Little is known about patterns of seizures that occur multiple times a day, sometimes called clusters or serial seizures.
OBJECTIVE: The online diary, My Epilepsy Diary (MED), provided self-reported data from community-based patients to describe the characteristics of clusters.
METHODS: We used MED data to define a population of 5098 community outpatients, including 1177 who specified time of multiple seizures in a 24-hour period. Outcomes included cluster prevalence and frequency, distribution of interseizure time intervals, as well as the types of triggers commonly reported.
RESULTS: One-fourth of days with any seizures included clusters for these patients. Most days with clusters included 2 seizures, with >5 events occurring in only 10% of days. One-third of seizures occurred within 3h of the initial event and two-thirds within 6h. When more than 2 seizures occurred, the time to the next seizure decreased from an average of over 2h (to the 3rd event) to a quarter-hour (from the 4th to the 5th event).
CONCLUSION: My Epilepsy Diary data have provided the first overview of cluster seizures in a large community-based population. Treatments with less than 3-hour duration of action would be bioavailable at the time of only one-third of subsequent seizures. Although limited by the self-reported and observational nature of the diary data, some general patterns emerge and can help to focus questions for future studies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clusters; Diaries; Epilepsy; Patient-reported outcomes; Seizures; Serial seizures

Mesh:

Substances:

Year:  2015        PMID: 26046724     DOI: 10.1016/j.yebeh.2015.04.022

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  12 in total

1.  Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.

Authors:  James W Wheless; Ian Miller; R Edward Hogan; Dennis Dlugos; Victor Biton; Gregory D Cascino; Michael R Sperling; Kore Liow; Blanca Vazquez; Eric B Segal; Daniel Tarquinio; Weldon Mauney; Jay Desai; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia       Date:  2021-08-21       Impact factor: 6.740

2.  Common data elements for epilepsy mobile health systems.

Authors:  Daniel M Goldenholz; Robert Moss; David A Jost; Nathan E Crone; Gregory Krauss; Rosalind Picard; Chiara Caborni; Jose E Cavazos; John Hixson; Tobias Loddenkemper; Tracy Dixon Salazar; Laura Lubbers; Lauren C Harte-Hargrove; Vicky Whittemore; Jonas Duun-Henriksen; Eric Dolan; Nitish Kasturia; Mark Oberemk; Mark J Cook; Mark Lehmkuhle; Michael R Sperling; Patricia O Shafer
Journal:  Epilepsia       Date:  2018-03-31       Impact factor: 5.864

3.  Monte Carlo simulations of randomized clinical trials in epilepsy.

Authors:  Daniel M Goldenholz; Joseph Tharayil; Robert Moss; Evan Myers; William H Theodore
Journal:  Ann Clin Transl Neurol       Date:  2017-05-24       Impact factor: 4.511

4.  Treatment diary for botulinum toxin spasticity treatment: a pilot study.

Authors:  Bo Biering-Sørensen; Helle K Iversen; Inge M S Frederiksen; Jeanet R Vilhelmsen; Fin Biering-Sørensen
Journal:  Int J Rehabil Res       Date:  2017-06       Impact factor: 1.479

5.  Characteristics of large patient-reported outcomes: Where can one million seizures get us?

Authors:  Victor Ferastraoaru; Daniel M Goldenholz; Sharon Chiang; Robert Moss; William H Theodore; Sheryl R Haut
Journal:  Epilepsia Open       Date:  2018-07-04

6.  Seizure Clusters, Seizure Severity Markers, and SUDEP Risk.

Authors:  Manuela Ochoa-Urrea; Nuria Lacuey; Laura Vilella; Liang Zhu; Shirin Jamal-Omidi; M R Sandhya Rani; Johnson P Hampson; Mojtaba Dayyani; Jaison Hampson; Norma J Hupp; Shiqiang Tao; Rup K Sainju; Daniel Friedman; Maromi Nei; Catherine Scott; Luke Allen; Brian K Gehlbach; Victoria Reick-Mitrisin; Stephan Schuele; Jennifer Ogren; Ronald M Harper; Beate Diehl; Lisa M Bateman; Orrin Devinsky; George B Richerson; Guo-Qiang Zhang; Samden D Lhatoo
Journal:  Front Neurol       Date:  2021-02-12       Impact factor: 4.003

Review 7.  Seizure Clusters: Morbidity and Mortality.

Authors:  Kristie Bauman; Orrin Devinsky
Journal:  Front Neurol       Date:  2021-02-16       Impact factor: 4.003

8.  Frequency of Seizure Clusters and Their Associated Risk Factors in Adult Patients with Epilepsy Referred to Epilepsy Center of Kashani Hospital in Isfahan from 2011 to 2016.

Authors:  Jafar Mehvari Habibabadi; Mohamad Zare; Seyed Navid Naghibi; Mahdieh Afzali; Iman Adibi; Nasim Tabrizi; Seyed Nader Naghibi
Journal:  Int J Prev Med       Date:  2020-02-17

9.  Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study.

Authors:  Michael R Sperling; James W Wheless; R Edward Hogan; Dennis Dlugos; Gregory D Cascino; Kore Liow; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia       Date:  2022-02-02       Impact factor: 6.740

10.  Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study.

Authors:  Ian Miller; James W Wheless; Robert E Hogan; Dennis Dlugos; Victor Biton; Gregory D Cascino; Michael R Sperling; Kore Liow; Blanca Vazquez; Eric B Segal; Daniel Tarquinio; Weldon Mauney; Jay Desai; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia Open       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.